Outcomes of adjuvant platinum-based chemotherapy or radiation therapy in completely resected stage I-IV uterine carcinosarcoma (uCS)

被引：0
|
作者：
Makker, V. [1 ]
Abu-Rustum, N. R. [1 ]
Aghajanian, C. A. [1 ]
Hensley, M. L. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.5560
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5560
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Utilization of Adjuvant Chemotherapy, Radiation Therapy, or Combined Modality Therapy and the Impact on Survival for Uterine Carcinosarcoma
    Wong, A. T.
    Schwartz, D.
    Lee, A.
    Shao, M.
    Han, P. Y.
    Schreiber, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E291 - E291
  • [22] Adjuvant platinum-based chemotherapy for early stage cervical cancer (Review)
    Rosa, Daniela D.
    Medeiros, Lidia R. F.
    Edelweiss, Maria I.
    Bozzetti, Mary C.
    Pohlmann, Paula R.
    Stein, Airton T.
    Dickinson, Heather O.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (03):
  • [23] Uterine serous carcinoma: Reassessing effectiveness of platinum-based adjuvant therapy
    Tortorella, Lucia
    Langstraat, Carrie L.
    Weaver, Amy L.
    McGree, Michaela E.
    Bakkum-Gamez, Jamie N.
    Dowdy, Sean C.
    Cliby, William A.
    Keeney, Gary L.
    Sherman, Mark E.
    Weroha, Saravut J.
    Mariani, Andrea
    Podratz, Karl C.
    GYNECOLOGIC ONCOLOGY, 2018, 149 (02) : 291 - 296
  • [24] Adjuvant Therapy Improves Outcomes in Completely Resected, Limited-Stage Follicular Lymphoma
    Andraos, T. Y.
    Ayoub, Z.
    Nastoupil, L.
    Milgrom, S. A.
    Pinnix, C. C.
    Ng, S. P.
    Fowler, N.
    Neelapu, S. S.
    Samaniego, F.
    Fayad, L.
    Dabaja, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S180 - S181
  • [25] Survival impact of pelvic and para-aortic lymph node sampling in patients with completely resected stage I-IV uterine serous carcinoma (USC)
    Acosta, N. M.
    Miller, E. M.
    Viswanathan, S.
    Hastings, V.
    Goldberg, G. L.
    Kuo, D. Y. S.
    Frimer, M.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 53 - 54
  • [26] A randomized, double blinded, multicenter phase 3 study of platinum-based chemotherapy with or without QL1706 as adjuvant therapy in completely resected stage II-IIIb NSCLC.
    Zhu, Yuming
    Jiang, Tao
    Fang, Lianghua
    Zhang, Tao
    Kang, Xiaoyan
    Zhou, Caicun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Significant pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients after adjuvant chemotherapy alone: Implications for adjuvant radiation therapy
    Mundt, AJ
    McBride, R
    Rotmensch, J
    Waggoner, SE
    Yamada, SD
    Connell, PP
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (05): : 1145 - 1153
  • [28] Platinum/Taxane-based Chemotherapy With or Without Radiation Therapy Favorably Impacts Survival Outcomes in Stage I Uterine Papillary Serous Carcinoma
    Fader, Amanda Nickles
    Drake, Richard D.
    O'Malley, David M.
    Gibbons, Heidi E.
    Huh, Warner K.
    Havrilesky, Laura J.
    Gehrig, Paola A.
    Tuller, Erin
    Axtell, Allison E.
    Zanotti, Kristine M.
    CANCER, 2009, 115 (10) : 2119 - 2127
  • [29] Impact of Platinum/Pemetrexed versus Other Platinum-Based Regimens on Adjuvant Chemotherapy in Resected Adenocarcinoma Lung Cancer
    Zhai, Xiaoyu
    Wang Ziping
    Yang, Lu
    Zhu, Yixiang
    Li, Junling
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S930 - S931
  • [30] Impact of platinum/pemetrexed combination versus other platinum-based regimens on adjuvant chemotherapy in resected lung adenocarcinoma
    Zhai, Xiaoyu
    Zheng, Qiwen
    Yang, Lu
    Zhu, Yixiang
    Li, Junling
    Liu, Yutao
    Wang, Ziping
    SCIENTIFIC REPORTS, 2017, 7
12345